Biomerica, Inc. (BMRA)
NASDAQ: BMRA · Real-Time Price · USD
2.340
+0.037 (1.61%)
At close: Dec 5, 2025, 4:00 PM EST
2.320
-0.020 (-0.85%)
After-hours: Dec 5, 2025, 7:19 PM EST
Biomerica Market Cap
Biomerica has a market cap or net worth of $6.90 million as of December 5, 2025. Its market cap has increased by 23.18% in one year.
Market Cap
6.90M
Enterprise Value
4.22M
1-Year Change
23.18%
Ranking
Category
Stock Price
$2.34
Market Cap Chart
Since December 1, 1998, Biomerica's market cap has increased from $6.70M to $6.90M, an increase of 2.96%. That is a compound annual growth rate of 0.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 6.60M | 32.00% |
| Dec 31, 2024 | 5.00M | -76.19% |
| Dec 29, 2023 | 21.00M | -53.33% |
| Dec 30, 2022 | 45.00M | -7.60% |
| Dec 31, 2021 | 48.70M | -16.75% |
| Dec 31, 2020 | 58.50M | 96.97% |
| Dec 31, 2019 | 29.70M | 92.86% |
| Dec 31, 2018 | 15.40M | -51.72% |
| Dec 29, 2017 | 31.90M | 69.68% |
| Dec 30, 2016 | 18.80M | 91.84% |
| Dec 31, 2015 | 9.80M | 46.27% |
| Dec 31, 2014 | 6.70M | 17.54% |
| Dec 31, 2013 | 5.70M | -3.39% |
| Dec 31, 2012 | 5.90M | 78.79% |
| Dec 30, 2011 | 3.30M | 17.86% |
| Dec 31, 2010 | 2.80M | 3.70% |
| Dec 31, 2009 | 2.70M | -20.59% |
| Dec 31, 2008 | 3.40M | -63.83% |
| Dec 31, 2007 | 9.40M | 291.67% |
| Dec 29, 2006 | 2.40M | -14.29% |
| Dec 30, 2005 | 2.80M | 16.67% |
| Dec 31, 2004 | 2.40M | -7.69% |
| Dec 31, 2003 | 2.60M | 136.36% |
| Dec 31, 2002 | 1.10M | -66.67% |
| Dec 31, 2001 | 3.30M | 73.68% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |